Last reviewed · How we verify
NCT03006731: HIIT-Stroke
High Intensity Interval Training for People With Stroke Deficits
NA trial testing High Intensity Interval Training in Stroke in 47 participants. Status unknown.
31 July 2022
Quick facts
| Lead sponsor | University Health Network, Toronto |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 47 |
| Start date | 1 March 2017 |
| Primary completion | 31 July 2022 |
| Estimated completion | 31 August 2023 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- High Intensity Interval Training
- Moderate Intensity Continuous Exercise
Conditions studied
- Stroke — all drugs for Stroke →
Sponsor
University Health Network, Toronto
Who can join
Eligibility, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to compare the effects of an exercise training strategy called high-intensity interval training (HIIT) to moderate intensity continuous exercise (MICE), on walking function and cardiovascular fitness in stroke patients. Hypothesis: HIIT will result in significantly greater benefit to fitness and mobility than MICE.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Treadmill training and body weight support for walking after stroke.
Mehrholz J, Thomas S, Elsner B. · · 2017 · cited 147× · PMID 28815562 · DOI 10.1002/14651858.cd002840.pub4 -
Effect of High-Intensity Interval Training and Moderate-Intensity Continuous Training in People With Poststroke Gait Dysfunction: A Randomized Clinical Trial.
Marzolini S, Robertson AD, MacIntosh BJ, Corbett D, et al · · 2023 · cited 20× · PMID 37947080 · DOI 10.1161/jaha.123.031532
Verify or expand the search:
- PubMed search for NCT03006731
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High Intensity Interval Training
Trials testing the same drug.
- NCT07484399 — Comparing Effects of HIIT and MICT on Functional Mobility, Muscle Strength, and Quality of Life in Diabetic Patients · NA · not yet recruiting
- NCT07534293 — Effects of 7-Day Creatine Supplementation on Cognitive Function After High-Intensity Interval Training in Active Young M · NA · completed
- NCT07188272 — Effect of High-intensity Interval Training Combined With DASH Diet on Arterial Stiffness in Hypertensive Patients · NA · completed
- NCT06860256 — Different Exercise Training Programs in University Students with Primary Dysmenorrhea · NA · not yet recruiting
- NCT06621550 — Effect of High-Intensity Interval Training Exercise on Cognitive Function of Young Adults · NA · recruiting
Other recruiting trials for Stroke
Currently open trials in the same condition.
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
- NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
- NCT07356011 — Exoskeleton for Balance · NA · recruiting
- NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
- NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting
Other University Health Network, Toronto trials
Trials by the same sponsor.
- NCT06831032 — Elective Adaptive Radiation With SBRT for Improved DurabilitY of Response · NA · recruiting
- NCT06634056 — Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients U · Phase 2 · not yet recruiting
- NCT06836726 — Clinical Trial to Test Efficacy of Targeting Hypoxia Combined With ARSI After First-line ARSI Therapy for Castrate Resis · Phase 2 · not yet recruiting
- NCT07515651 — Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas · Phase 2 · not yet recruiting
- NCT07509450 — Fecal Microbiota Transplantation in Patients Undergoing Chimeric Antigen Receptor T-cell Therapy and Allogeneic Stem Cel · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03006731 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Health Network, Toronto
- Last refreshed: 9 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03006731.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing